Russian hospital network Medsi, backed by listed investor Sistema Capital, has launched a franchise model to grow its network of clinics. The move could be a way for the group to expand beyond Moscow where most of its business is concentrated.
HBI hears the market for manager-level medical checkups is worth around €1.5bn each year in Germany but this is predominately private pay. The occupational healthcare market feels like it's being held back by reimbursement models that don't support wider preventive care.
Since the end of October, healthcare real-estate investor Aedifica has acquired five sites in Germany and put in a public tender offer to acquire 100% of Finnish healthcare property developer Hoivatilat. We speak to the company's chief investment officer about the details.
There was speculation over the summer that the UK's biggest dental player by revenue, Mydentist (rebranded from IDH) was set to sell - and then all went quiet, drowned out in part by noise about Brexit and a possible election. But a sale is definitely on the cards next year and HBI hears rumours that investor Carlyle has been tentatively seeking earlier suitors for an accelerated exclusive bilateral deal before Christmas - though sources close to the company dismiss this suggestion out of hand.
Finnish health tech specialist My Nightingale has launched a €50-80m private funding round to develop an app which would bring a preventative blood testing services to individual patients.
Listed Romanian healthcare group Medlife has acquired a private outpatient clinic chain in the country's eastern region of Moldova, adding €3.8m of 2018 sales.
European nursing home operator DomusVi has acquired two facilities in Chile through its subsidiary Acalis as part of a rapid expansion strategy across the region. This is the group's second acquisition in Latin America, as growth has otherwise been focused on greenfield. We speak to the CEO of Acalis Latam about the group's regional strategy.
Shares in under-fire Fortis, the large Indian hospital chain targeted by pan-Asian group IHH, dropped by almost 8% following a ruling by the Indian Supreme Court that Fortis' founders were guilty of contempt on Friday for not settling a debt, adding that similar proceedings against Fortis could follow. The IHH deal is now on hold. Could it be in jeopardy?
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.